The change in body weight from baseline was 13.3% and 2.6% in the semaglutide and placebo groups, respectively
106 U/L, 119 U/L and 141 U/L, respectively, normal laboratory range 034 U/L)
Patient safety considerations include monitoring for dehydration, especially if laxative use leads to loose stools or diarrhea in someone already experiencing nausea or reduced fluid intake
Vomiting: Along with nausea, some people might also experience vomiting
Once opened and in active use, your pen or vial can remain at room temperature up to 77F for up to 28 days, allowing flexibility during daily life without constant refrigeration
Practical Tools, Real Results Access a wealth of templatesfrom intake forms to medication protocolsfor seamless integration into your clinic